Navitor Pharmaceuticals

About:

Navitor Pharma is a developer of novel medicines designed to target specific nutrient-sensing proteins to treat diseases.

Website: http://www.navitorpharma.com/

Twitter/X: NavitorPharma

Top Investors: Polaris Partners, SR One, Atlas Venture, Johnson & Johnson Robotics and Digital Solutions, Johnson & Johnson Development Corporation

Description:

Navitor Pharmaceuticals is a developer of novel medicines designed to target specific nutrient-sensing proteins that selectively regulate mTORC1 activity to treat diseases. The company's medicines selectively modulate the activity of mTORC1, a master regulator of cell growth and metabolism, and unlock the therapeutic potential of the mTOR pathway by targeting the amino acid and other nutrient sensors that selectively regulate the activity of mTORC1, enabling healthcare practitioners to address a wide range of metabolic, neurodegenerative, autoimmune and musculoskeletal diseases. It was founded in 2009 and headquartered in Cambridge, Massachusetts.